MXPA02001614A - Factor de transcripcion novedoso, bp1. - Google Patents

Factor de transcripcion novedoso, bp1.

Info

Publication number
MXPA02001614A
MXPA02001614A MXPA02001614A MXPA02001614A MXPA02001614A MX PA02001614 A MXPA02001614 A MX PA02001614A MX PA02001614 A MXPA02001614 A MX PA02001614A MX PA02001614 A MXPA02001614 A MX PA02001614A MX PA02001614 A MXPA02001614 A MX PA02001614A
Authority
MX
Mexico
Prior art keywords
transcription factor
novel transcription
novel
factor
transcription
Prior art date
Application number
MXPA02001614A
Other languages
English (en)
Inventor
Patricia E Berg
Original Assignee
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ George Washington filed Critical Univ George Washington
Publication of MXPA02001614A publication Critical patent/MXPA02001614A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
MXPA02001614A 1999-08-13 2000-08-14 Factor de transcripcion novedoso, bp1. MXPA02001614A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14894099P 1999-08-13 1999-08-13
PCT/US2000/022093 WO2001012648A1 (en) 1999-08-13 2000-08-14 Novel transcription factor, bp1

Publications (1)

Publication Number Publication Date
MXPA02001614A true MXPA02001614A (es) 2003-07-21

Family

ID=22528120

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02001614A MXPA02001614A (es) 1999-08-13 2000-08-14 Factor de transcripcion novedoso, bp1.

Country Status (10)

Country Link
US (2) US6416956B1 (es)
EP (1) EP1633769A1 (es)
JP (1) JP2003507028A (es)
CN (1) CN1378552A (es)
AU (1) AU767733B2 (es)
CA (1) CA2381863A1 (es)
HK (1) HK1049846A1 (es)
IL (1) IL148012A0 (es)
MX (1) MXPA02001614A (es)
WO (1) WO2001012648A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005022149A1 (en) * 2003-08-28 2005-03-10 Coopersurgical, Inc. Method for determining embryo quality
US20050221341A1 (en) * 2003-10-22 2005-10-06 Shimkets Richard A Sequence-based karyotyping
US7228975B2 (en) * 2004-04-22 2007-06-12 Simplehuman Llc Dish rack with swinging arm
CA2585985A1 (en) * 2004-11-17 2006-05-26 Mosaic Reproductive Health And Genetics, Llc Methods of developing a stem cell line
US7662183B2 (en) * 2006-01-24 2010-02-16 Timothy Haines Dynamic spinal implants incorporating cartilage bearing graft material
CN101275134B (zh) * 2007-04-20 2010-06-02 清华大学深圳研究生院 治疗乳腺癌的药物及其专用反义寡核苷酸
BRPI0817233A2 (pt) * 2007-09-28 2012-11-06 Intrexon Corp construções terapêuticas de gene de trca e bireatores para a expressão de moléculas bioterapêuticas, e usos das mesmas
PT2506840T (pt) 2009-12-04 2021-04-27 Oncoc4 Inc Utilizações de inibidores de fatores induzíveis de hipoxia
US20120295286A1 (en) * 2011-04-21 2012-11-22 The George Washington University Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1
CN104277102B (zh) * 2014-06-27 2017-04-12 李光辉 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332665T2 (de) 1992-03-11 2003-11-27 Dana Farber Cancer Inst Inc Methode um mrna zu klonieren
US5677125A (en) 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5700927A (en) 1994-12-23 1997-12-23 The Children's Medical Center Corporation Tbc1 gene and uses thereof
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
WO1997006256A2 (en) 1995-08-09 1997-02-20 Institut National De La Sante Et De La Recherche Medicale Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
US5994062A (en) 1995-10-02 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
US5776683A (en) 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US6037129A (en) 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer

Also Published As

Publication number Publication date
US7176294B2 (en) 2007-02-13
JP2003507028A (ja) 2003-02-25
US20030171273A1 (en) 2003-09-11
IL148012A0 (en) 2002-09-12
EP1633769A4 (en) 2006-03-15
US6416956B1 (en) 2002-07-09
WO2001012648A1 (en) 2001-02-22
HK1049846A1 (zh) 2003-05-30
AU6902900A (en) 2001-03-13
CN1378552A (zh) 2002-11-06
AU767733B2 (en) 2003-11-20
EP1633769A1 (en) 2006-03-15
CA2381863A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200103880B (en) Catalyst.
ZA200200477B (en) 2-pyrazolin-5-ones.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200205479B (en) Novel biarylcarboxamides.
HK1052037A1 (en) Structural member.
ZA200210206B (en) Expression system.
ZA200202537B (en) Pour-on-formulations.
HK1051199A1 (en) New phenylpiperazines.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
ZA200203177B (en) Regeneration.
MXPA02001614A (es) Factor de transcripcion novedoso, bp1.
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
MXPA02000261A (es) Aminoindanos novedosos.
GB0029278D0 (en) I.S. Machine
GB0029720D0 (en) I.S machine7544232001
GB2347421B (en) I.S. machine
MXPA03000664A (es) Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
ZA992018B (en) Banners.
MXPA01010701A (es) Vacuna.
GB9914600D0 (en) Novel,process
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.
ZA200201714B (en) Novel compound F-15078.
GB2349384B (en) I.S. machine